Markets

Insider Trading

Hedge Funds

Retirement

Opinion

5 Best Bear Market Stocks to Invest In Right Now

In this article, we will take a look at the 5 Best Bear Market Stocks to Invest In Right Now. For deeper discussion and analysis, have a look at the 10 Best Bear Market Stocks to Invest In Right Now. 

Photo by Dan Dennis on Unsplash

5. PepsiCo, Inc. (NASDAQ:PEP)

Number of Hedge Fund Holders: 74

On April 20, Lauren Lieberman of Barclays raised the firm’s price recommendation on PepsiCo, Inc. (NASDAQ:PEP) to $158 from $154. It reiterated an Equal Weight rating following earnings. She said PepsiCo Foods North America “finally delivered the volume inflection investors have been waiting for.” At the same time, she noted the company now needs to show that these results can be sustained.

On April 22, PepsiCo announced a multi-year strategic collaboration with Google Cloud. The goal is to strengthen its digital foundation and use the Gemini Enterprise Agent Platform to help teams move from insight to action more quickly and consistently at scale. PepsiCo is working with Google Cloud to reshape its IT ecosystem and advance its multi-cloud strategy. The partnership is designed to give the company more flexibility in using AI tools to address complex business challenges, including supply chain management and go-to-market execution. By moving to Google Cloud’s secure global infrastructure, PepsiCo plans to build new digital capabilities across its operations.

PepsiCo, Inc. (NASDAQ:PEP) operates as a global food and beverage company. It manufactures, markets, and distributes products such as Pepsi, Lay’s, Gatorade, and Quaker across more than 200 countries.

4. Philip Morris International Inc. (NYSE:PM)

Number of Hedge Fund Holders: 82

On April 22, Reuters reported that Philip Morris International Inc. (NYSE:PM) lowered its annual profit forecast amid regulatory uncertainty around its Zyn nicotine pouches and rising competition in tobacco products. The company has been pushing to move beyond cigarettes. At the same time, it is facing stronger competition from alternatives such as British American Tobacco’s Velo, along with delays in getting approval for new Zyn products.

CFO Emmanuel Babeau said a complex regulatory environment continues to slow innovation and the transition of adult smokers to smoke-free products. Philip Morris now expects full-year adjusted EPS of $8.36 to $8.51, down from its earlier forecast of $8.38 to $8.53. The midpoint is about $0.04 above analysts’ expectations, based on data compiled by LSEG.

The company added that it has included a small impact from the Middle East conflict in its outlook, but does not expect any prolonged effect. Shares rose about 6% after strength in its international smoke-free business helped deliver a first-quarter beat. Quarterly revenue came in at $10.15 billion, ahead of estimates of $9.91 bilion. Adjusted EPS was $1.96, above expectations of $1.83. US Zyn shipments declined 23.5%, which the company linked mainly to inventory adjustments by distributors and retailers. In contrast, shipments for its international smoke-free segment increased 11.9%.

Philip Morris International Inc. (NYSE:PM) is an international tobacco company. Its portfolio includes cigarettes and smoke-free products. The smoke-free business also covers wellness and healthcare products, along with consumer accessories such as lighters and matches.

3. Chevron Corporation (NYSE:CVX)

Number of Hedge Fund Holders: 86

On April 22, Scotiabank raised its price recommendation on Chevron Corporation (NYSE:CVX) to $187 from $168. It reiterated a Sector Perform rating on the shares. The firm said it is updating price targets for US Integrated Oil, Refining, and Large Cap E&P companies under its coverage. Its view on the sector remains mixed. It is generally above consensus earnings estimates for the E&P group, while sitting below expectations for independent refiners. Looking ahead, the firm expects investor focus to shift toward whether recent volatility in the oil market will affect activity levels in 2026 and beyond.

On April 23, Reuters reported that Chevron had fully restored production at its Wheatstone LNG facility in Western Australia after completing repairs tied to cyclone damage from the prior month. The company said Tropical Cyclone Narelle hit the 8.9 million-ton-per-year plant in late March, forcing both LNG processing trains offline.

Danny Woodall, director of operations and maintenance for Australia, said the cyclone’s extreme winds damaged several hundred air-cooled heat exchangers, known as fin fans, making the repair process both extensive and complex. He added that domestic gas supply for Western Australian customers was restored within about a week, while LNG production returned gradually over time.

Chevron Corporation (NYSE:CVX) is an integrated energy company. It produces crude oil and natural gas, manufactures transportation fuels, lubricants, petrochemicals, and additives, and develops technologies to support its operations and the broader industry.

2. Merck & Co., Inc. (NYSE:MRK)

Number of Hedge Fund Holders: 100

On April 22, Merck & Co., Inc. (NYSE:MRK) and Google Cloud announced a major partnership aimed at strengthening Merck’s digital backbone as an AI-enabled enterprise. The multi-year investment, valued at up to $1 billion, will introduce an agentic platform across research and development, manufacturing, commercial, and corporate functions. It also includes Google Cloud engineers working directly with Merck teams to deploy advanced AI tools, including Gemini Enterprise.

The partnership brings together Merck’s scientific and data capabilities with Google Cloud’s AI and cloud platforms. The goal is to digitize data and improve productivity across the company’s global workforce of 75,000 employees, supporting its focus on improving and saving lives. By combining their expertise, the two companies plan to build advanced AI solutions using Google Cloud technology. The effort is expected to support scientific innovation and improve operational performance.

Merck & Co., Inc. (NYSE:MRK) is a global healthcare company that provides health solutions through prescription medicines, including biologic therapies, vaccines, and animal health products. Its Pharmaceutical segment includes human health pharmaceutical and vaccine products.

1. Walmart Inc. (NASDAQ:WMT)

Number of Hedge Fund Holders: 114

On April 22, Morgan Stanley raised its price recommendation on Walmart Inc. (NASDAQ:WMT) to $140 from $135. It reiterated an Overweight rating on the shares. After meetings with management, including President and CEO John Furner and EVP and CFO John David Rainey, the firm said Walmart continues to benefit from its scale and technology. It also noted that the third-party marketplace and membership offerings are “running strong.”

On April 16, Walmart said it is expanding its Better Care Services platform. The aim is to better support customers looking for weight management and overall health solutions by bringing virtual care, nutrition guidance, and pharmacy access into one place. The platform now includes services for people using or considering GLP-1 therapies. It also offers access to medications through Walmart’s nationwide pharmacy network, including options like Foundayo.

It connects users with providers such as Aaptiv, Berry Street, Curai Health, MyCare by Twin Health, and Wheel. These services include fitness programs, dietitian support, AI-driven coaching, and telehealth care. Prescription fulfillment is handled through Walmart Pharmacy, with integrations such as LillyDirect. Additional tools, including the Nutrition Hub and an updated GLP-1 section on Walmart.com, are designed to support healthier lifestyle choices.

Walmart Inc. (NASDAQ:WMT) is a technology-powered omnichannel retailer. It operates retail and wholesale stores and clubs, along with eCommerce websites and mobile apps, across the United States, Africa, Canada, Central America, Chile, China, India, and Mexico. The company reports through three segments: Walmart U.S., Walmart International, and Sam’s Club U.S.

While we acknowledge the potential of WMT as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than WMT and that has 100x upside potential, check out our report about the cheapest AI stock.

READ NEXT: 10 Monthly Dividend Stocks To Buy and 10 Best US Stocks to Invest In for Long Term

Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below.

The $250 Trillion AI Hype is Real. A few years from now, you’ll probably wish you’d bought this stock.

Dr. Inan Dogan

Dr. Ian Dogan

Co-Founder and Research Director at Insider Monkey

When Jeff Bezos said that one breakthrough technology would shape Amazon’s destiny, even Wall Street’s biggest analysts were caught off guard.

Fast forward a year and Amazon’s new CEO Andy Jassy described generative AI as a “once-in-a-lifetime” technology that is already being used across Amazon to reinvent customer experiences.

At the 8th Future Investment Initiative conference, Elon Musk predicted that by 2040 there would be at least 10 billion humanoid robots, with each priced between $20,000 and $25,000.

Do the math. According to Musk, this technology could be worth $250 trillion by 2040.

Put another way, that’s roughly equal to:

  • 175 Teslas
  • 107 Amazons
  • 140 Metas
  • 84 Googles
  • 65 Microsofts
  • And 55 Nvidias

And here’s the wild part — this $250 trillion wave isn’t tied to one company, but to an entire ecosystem of AI innovators set to reshape the global economy.

It’s a leap so massive, it could reshape how businesses, governments, and consumers operate worldwide.

Even if that $250 trillion figure sounds ambitious, major firms like PwC and McKinsey still see AI unlocking multi-trillion-dollar potential.

How could anything be worth that much?

The answer lies in a breakthrough so powerful it’s redefining how humanity works, learns, and creates.

And this breakthrough has already set off a frenzy among hedge funds and Wall Street’s top investors.

What most investors don’t realize is that one under-owned company holds the key to this $250 trillion revolution.

In fact, Verge argues this company’s supercheap AI technology should concern rivals.

Before I reveal the details, let’s talk about how some of the richest people on the planet are positioning themselves.

  • Bill Gates sees artificial intelligence as the “biggest technological advance in my lifetime,” more transformative than the internet or personal computer, capable of improving healthcare, education, and addressing climate change.
  • Larry Ellison — through Oracle, is spending billions on Nvidia chips and partnering with Cohere to embed generative AI across Oracle’s cloud and apps.
  • Warren Buffett — not known for tech hype — says this breakthrough could have a ‘hugely beneficial social impact.

When billionaires from Silicon Valley to Wall Street line up behind the same idea — you know it’s worth paying attention to.

Even as we admire what Tesla, Nvidia, Alphabet, and Microsoft have built, we believe an even greater opportunity lies elsewhere…

But the real story isn’t Nvidia — it’s a much smaller company quietly improving the critical technology that makes this entire revolution possible.

And judging by what I’m hearing from both Silicon Valley insiders and Wall Street veterans…

This prediction might not be bold at all:

A few years from now, you’ll wish you’d owned this stock.

The best part? You can discover everything about this company and its groundbreaking technology right now.

I’ve compiled everything you need to know about this groundbreaking company in a detailed, members-only report.

Trust me — you’ll want to read this report before putting another dollar into any tech stock.

For a ridiculously low price of just $9.99 a month, you can unlock a year’s worth of in-depth investment research and exclusive insights – that’s less than a single fast food meal!

Here’s what to do next:

1. Subscribe to our Premium Readership Newsletter for just $9.99 a month. (33% Off – was $14.99).

2. Enjoy a year of ad-free browsing, exclusive access to our in-depth report on the revolutionary AI company, and the upcoming issues of our Premium Readership Newsletter over the next 12 months.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!

<b>Cancel anytime.</b> Turn off auto-renewal via our website with just a click.

 

Buy This $3 Stock Now Before the 400% Surge Begins

Dr. Inan Dogan

Dr. Ian Dogan

Co-Founder and Research Director at Insider Monkey

My name is Inan Dogan. I’m the co-founder and Research Director of Insider Monkey. I have an important message for you today.

Since March 2017, my stock picks have returned 16.5% annually. Today, I’ve found an opportunity even bigger than my British American Tobacco call.

Two years ago, Wall Street wrote off British American Tobacco (BTI) as a “melting ice cube.” The stock had crashed 40% from its peak, and consensus said the business was dying.

We looked under the cover and realized they were wrong.

We alerted our subscribers, and BTI returned 90% in just 16 months.

Now if you had invested just $10,000 in BTI in June 2024, you’d be sitting on $19,000 in October 2025.

Today, we have identified a nearly identical pattern in a digital-first giant trading at $3.

While the market panics over a surface-level revenue decline, our PhD-led research shows management has actually surgically cut $100 million in waste to focus on high-margin growth.

This pattern is a hallmark of our 16.5% annual return track record. The current opportunity offers a 400% upside potential—dwarfing even our 90% BTI return.

Get the ticker for our new “Underdog” pick and the full BTI case study for just 99 cents.

This exclusive offer is for NEW newsletter subscribers ONLY! Join our Premium Readership Newsletter for only $0.99 and become part of a savvy investor community.!

This offer vanishes in 7 days, so don’t miss your chance to lock in market beating returnsSign up NOW! The monthly newsletter comes with a 30-day, no-risk money-back guarantee. This offer is available to the first 1000 new investors who respond.

Regular price $9.99/mo. Cancel anytime.

Space is Limited! Only 1000 spots are available for this exclusive offer. Don’t let this chance slip away – subscribe to our Premium Readership Newsletter today and unlock the potential for a life-changing investment.

Here’s what to do next:

1. Head over to our website and subscribe to our Premium Readership Newsletter for just $0.99.

2. Enjoy a month of ad-free browsing, exclusive access to our in-depth report on the Trump tariff and nuclear energy company as well as the revolutionary AI-robotics company, and the upcoming issues of our Premium Readership Newsletter.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!

Regular price $9.99/mo. Cancel anytime.